Accès gratuit
Numéro
Réanimation
Volume 25, Numéro 3, Mai 2016
Infectieux
Page(s) 348 - 360
Section Mise Au Point / Update
DOI https://doi.org/10.1007/s13546-016-1199-y
Publié en ligne 22 avril 2016
  • Ellis M (1997) Fungal endocarditis. J Infect 35:99–103 [CrossRef] [PubMed] [Google Scholar]
  • Rubinstein E, Lang R (1995) Fungal endocarditis. Eur Heart J 16(Suppl B):84–9 [CrossRef] [Google Scholar]
  • Varghese GM, Sobel JD (2008) Fungal endocarditis. Curr Infect Dis Rep 10:275–9 [CrossRef] [PubMed] [Google Scholar]
  • Pierrotti LC, Baddour LM (2002) Fungal endocarditis, 1995-2000. Chest 122:302–10 [CrossRef] [PubMed] [Google Scholar]
  • Rubinstein E, Noriega ER, Simberkoff MS, et al (1975) Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore) 54:331–4 [PubMed] [Google Scholar]
  • Ellis ME, Al-Abdely H, Sandridge A, et al (2001) Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis Off Publ Infect Dis Soc Am 32:50–62 [CrossRef] [Google Scholar]
  • Arnold CJ, Johnson M, Bayer AS, et al (2015) Candida infective endocarditis: an observational cohort study with a focus on therapy. Antimicrob Agents Chemother 59:2365–73 [CrossRef] [PubMed] [Google Scholar]
  • Lefort A, Chartier L, Sendid B, et al (2012) Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18:E99–109 [Google Scholar]
  • Baddley JW, Benjamin DK, Patel M, et al (2008) Candida infective endocarditis. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 27:519–29 [CrossRef] [Google Scholar]
  • Falcone M, Barzaghi N, Carosi G, et al (2009) Candida infective endocarditis: report of 15 cases from a prospective multicenter study. Medicine (Baltimore) 88:160–8 [CrossRef] [PubMed] [Google Scholar]
  • Selton-Suty C, Célard M, Le Moing V, et al (2012) Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis Off Publ Infect Dis Soc Am 54:1230–9 [CrossRef] [Google Scholar]
  • Bor DH, Woolhandler S, Nardin R, et al (2013) Infective endocarditis in the U.S., 1998-2009: a nationwide study. PloS One 8:e60033 [CrossRef] [PubMed] [Google Scholar]
  • Kalokhe AS, Rouphael N, El Chami MF, et al (2010) Aspergillus endocarditis: a review of the literature. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 14:e1040–7 [Google Scholar]
  • Rivière S, Lortholary O, Michon J, et al (2013) Aspergillus endocarditis in the era of new antifungals: major role for antigen detection. J Infect 67:85–8 [CrossRef] [PubMed] [Google Scholar]
  • Fernández-Cruz A, Cruz Menárguez M, Muñoz P, et al (2015) The search for endocarditis in patients with candidemia: a systematic recommendation for echocardiography? A prospective cohort. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 34:1543–9 [CrossRef] [PubMed] [Google Scholar]
  • Pappas PG, Kauffman CA, Andes DR, et al (2016) Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am 62:e1–50 [CrossRef] [Google Scholar]
  • Cuenca-Estrella M, Verweij PE, Arendrup MC, et al (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18(Suppl 7):9–18 [Google Scholar]
  • Baron EJ, Miller JM, Weinstein MP, et al (2013) A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis Off Publ Infect Dis Soc Am 57:e22–121 [CrossRef] [PubMed] [Google Scholar]
  • Habib G, Hoen B, Tornos P, et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 30:2369–413 [CrossRef] [PubMed] [Google Scholar]
  • Clancy CJ, Nguyen MH (2013) Finding the “missing 50%” of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care. Clin Infect Dis Off Publ Infect Dis Soc Am 56:1284–92 [CrossRef] [PubMed] [Google Scholar]
  • Pfeiffer CD, Samsa GP, Schell WA, et al (2011) Quantitation of Candida CFU in initial positive blood cultures. J Clin Microbiol 49:2879–83 [CrossRef] [PubMed] [Google Scholar]
  • Mikulska M, Calandra T, Sanguinetti M, et al (2010) The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care Lond Engl 14:R222 [CrossRef] [Google Scholar]
  • Koo S, Bryar JM, Page JH, et al (2009) Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis Off Publ Infect Dis Soc Am 49:1650–9 [CrossRef] [Google Scholar]
  • Azoulay E, Guigue N, Darmon M, et al (2016) (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies. Oncotarget [in press] [PubMed] [Google Scholar]
  • Poissy J, Sendid B, Damiens S, et al (2014) Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation. Crit Care Lond Engl 18:R135 [CrossRef] [PubMed] [Google Scholar]
  • Hachem RY, Kontoyiannis DP, Chemaly RF, et al (2009) Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 47:129–33 [CrossRef] [PubMed] [Google Scholar]
  • Imbert S, Gauthier L, Joly I, et al (2016) Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and non-neutropenic patients. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis [in press] [Google Scholar]
  • McCormack J, Pollard J (2011) Aspergillus endocarditis 2003-2009. Med Mycol 49(Suppl 1):S30–4 [CrossRef] [PubMed] [Google Scholar]
  • Badiee P, Alborzi A, Shakiba E, et al (2009) Molecular diagnosis of Aspergillus endocarditis after cardiac surgery. J Med Microbiol 58:192–5 [CrossRef] [PubMed] [Google Scholar]
  • Roberts JA, Lipman J (2009) Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 37:840–51 [CrossRef] [PubMed] [Google Scholar]
  • Habib G, Lancellotti P, Antunes MJ, et al (2015) 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36:3075–128 [CrossRef] [PubMed] [Google Scholar]
  • Baddour LM, Wilson WR, Bayer AS, et al (2015) Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation 132:1435–86 [CrossRef] [PubMed] [Google Scholar]
  • Cornely OA, Bassetti M, Calandra T, et al (2012) ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18(Suppl 7):19–37 [Google Scholar]
  • Pappas PG, Kauffman CA, Andes D, et al (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am 48:503–35 [CrossRef] [PubMed] [Google Scholar]
  • Gould FK, Denning DW, Elliott TS, et al (2012) Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 67:269–89 [CrossRef] [PubMed] [Google Scholar]
  • Kuse ER, Chetchotisakd P, da Cunha CA, et al (2007) Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet Lond Engl 369:1519–27 [CrossRef] [Google Scholar]
  • Kuhn DM, George T, Chandra J, et al (2002) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and échinocandins. Antimicrob Agents Chemother 46:1773–80 [CrossRef] [PubMed] [Google Scholar]
  • Jiménez-Expósito MJ, Torres G, Baraldés A, et al (2004) Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment. Clin Infect Dis Off Publ Infect Dis Soc Am 39:e70–3 [CrossRef] [Google Scholar]
  • Talarmin JP, Boutoille D, Tattevin P, et al (2009) Candida endocarditis: role of new antifungal agents. Mycoses 52:60–6 [CrossRef] [PubMed] [Google Scholar]
  • Lye DCB, Hughes A, O’Brien D, Athan E (2005) Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 24:753–5 [CrossRef] [Google Scholar]
  • Ripp SL, Aram JA, Bowman CJ, et al (2012) Tissue distribution of anidulafungin in neonatal rats. Birth Defects Res B Dev Reprod Toxicol 95:89–94 [PubMed] [Google Scholar]
  • Smego RA, Ahmad H (2011) The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis. Medicine (Baltimore) 90:237–49 [CrossRef] [PubMed] [Google Scholar]
  • Herbrecht R, Denning DW, Patterson TF, et al (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–15 [CrossRef] [PubMed] [Google Scholar]
  • Louie A, Banerjee P, Drusano GL, et al (1999) Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans. Antimicrob Agents Chemother 43:2841–7 [PubMed] [Google Scholar]
  • Melgar GR, Nasser RM, Gordon SM, et al (1997) Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital. Medicine (Baltimore) 76:94–103 [CrossRef] [PubMed] [Google Scholar]
  • Patel R (1998) Antifungal agents. Part I. Amphotericin B preparations and flucytosine. Mayo Clin Proc 73:1205–25 [CrossRef] [PubMed] [Google Scholar]
  • Vermes A, Guchelaar HJ, Dankert J (2000) Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 46:171–9 [CrossRef] [PubMed] [Google Scholar]
  • Steinbach WJ, Perfect JR, Cabell CH, et al (2005) A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect 51:230–47 [CrossRef] [PubMed] [Google Scholar]
  • Rubinstein E, Noriega ER, Simberkoff MS, Rahal JJ (1974) Tissue penetration of amphotericin B in Candida endocarditis. Chest 66:376–7 [CrossRef] [PubMed] [Google Scholar]
  • Utley JR, Mills J, Roe BB (1975) The role of valve replacement in the treatment of fungal endocarditis. J Thorac Cardiovasc Surg 69:255–8 [PubMed] [Google Scholar]
  • Escande W, Fayad G, Modine T, et al (2011) Culture of a prosthetic valve excised for streptococcal endocarditis positive for Aspergillus fumigatus 20 years after previous A fumigatus endocarditis. Ann Thorac Surg 91:e92–3 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.